Jiangsu Hengrui Pharmaceuticals
Merck agrees on $2.2bn deal with Quotient Therapeutics to develop IBD treatment
Quotient’s somatic genomics platform technology will be used to develop the treatment
Moderna and Merck announce data from melanoma combination therapy study
Skin cancer is one of the most common cancers in the US, with melanoma accounting for the majority of skin cancer deaths
Merck announces agreement with US government to reduce prices of prescription medication
The pharma company will invest more than $70bn in the US to boost production and innovation
Merck agrees deal with Cidara Therapeutics worth almost $9.2bn
Cidara’s long-acting viral flu drug showed significant protection in phase 2 results
Amgen reports positive results from landmark cardiovascular study
The study found significant reductions of major cardiovascular events in high-risk adults following treatment
Merck ends development agreement with Dr Falk Pharma for monoclonal antibody
Merck will take full control of developing MK-8690, an investigational monoclonal antibody candidate
Merck and Blackstone agree on funding for cancer protein antibody
The funding will support late-stage clinical development of the investigational antibody-drug conjugate
David Weinreich appointed as Merck’s head of R&D and CMO for healthcare
Weinreich brings clinical development and venture capital experience to the role
AstraZeneca and Merck decision to disinvest in the UK is a ‘tragedy’ for British research and innovation
Kate Shaw comments on the latest news about AstraZeneca and Merck's decision to hold planned investments in the UK
Eli Lilly’s Mounjaro shown to provide cardiovascular protection in type 2 diabetes patients
Approximately 38.4 million people in the US are affected by diabetes
MSD receives NICE recommendation for Keytruda in advanced endometrial cancer
More than 9,700 new cases of endometrial cancer are diagnosed every year in the UK
Merck unveils $3bn cost-cutting plan to support pipeline and new product launches
A new restructuring programme has been approved to support the initiative